1. The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial
- Author
-
Rashidi, Batool Hossein, Sarvi, Fatemeh, Tehrani, Ensieh Shahrokh, Zayeri, Farid, Movahedin, Mansoureh, and Khanafshar, Navid
- Subjects
- *
CLINICAL trials , *MEDICAL research , *PREGNANCY , *CONCEPTION - Abstract
Abstract: Objective:: To compare the effect of HMG and rhFSH on oocyte quality in ICSI cycle. Setting:: Vali-e-Asr university teaching hospital. Method:: Prospective single-blind randomized clinical trial. Subjects:: Sixty women undergoing ovarian stimulation for ICSI were randomized to receive a standard protocol of either HMG or rhFSH in down-regulation cycles. Interventions:: Prior to microinjection, each oocyte was assessed regarding the nuclear maturity, morphology of zona plucida, cytoplasmic appearance and polar body morphology. Fertilization rate was followed. Main outcome:: The percentage of metaphase II oocytes in HMG and rhFSH groups. Statistical analysis:: Statistical analyses were carried out by the Mann–Whitney, Fisher''s exact, χ 2 tests and Student''s t-test. Results:: No significant differences were found between two groups in regard to the demographic data, the ovarian response and pregnancy/implantation rates (P >0.05). The percentage of metaphase II oocytes in HMG and rhFSH groups were 81.3% versus 80.6%, respectively. Conclusions:: There were no significant differences between parameters such as, oocyte quality and percentage of metaphase II oocytes between these two groups. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF